Metoclopramide Tablet
NDC 68071-5314
Product Information
Metoclopramide is a ANDA-approved product labeled by Nucare Pharmaceuticals,inc.. This medication is typically used as a dopamine d2 antagonists [moa]. It is supplied as a white tablet for oral administration. This product entry covers the primary NDC 68071-5314 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
RF;10
Code Structure Chart
Product Details
What is NDC 68071-5314?
What are Active Ingredients of this product?
- METOCLOPRAMIDE HYDROCHLORIDE 5 mg/1 - A dopamine D2 antagonist that is used as an antiemetic.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- METOCLOPRAMIDE HYDROCHLORIDE (UNII: W1792A2RVD)
- METOCLOPRAMIDE (UNII: L4YEB44I46) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- STARCH, CORN (UNII: O8232NY3SJ)
- STEARIC ACID (UNII: 4ELV7Z65AP)
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.
Patient Education
Metoclopramide
Metoclopramide is used to treat gastroesophageal reflux disease (GERD; condition in which backward flow of acid from the stomach causes heartburn and injury of the esophagus) and gastroparesis (slow stomach emptying) . Metoclopramide is in a class of medications called prokinetic agents. It works by speeding the movement of food through the stomach and intestines.
[Learn More]
* Please review the full disclaimer at the bottom of this page.